Skip to content

Preoperative Loading With Carbohydrates in Lung Cancer Surgery

Preoperative Loading With Carbohydrates in Lung Cancer Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03070626
Enrollment
104
Registered
2017-03-03
Start date
2017-03-20
Completion date
2020-01-31
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasm

Keywords

General Surgery, Carbohydrates, Perioperative

Brief summary

Administration of preoperative oral carbohydrates are suggested to reduce insulin resistance due to surgical stress. The aim of this study is to investigate whether preoperative oral carbohydrate loading can contribute to lower incidence of postoperative discomfort and to reduce complications in elective lung cancer patients undergoing video assisted thorascopic surgery (VATS).

Detailed description

Fasting from 6-12hours before elective surgery is still standard of care in many departements, including our departement in Oslo University Hospital. Surgery is a trauma that triggers a catabolic stress response with high emissions of hormones and immune activation. These activations can affect brain, heart, muscles and liver. The metabolic changes may in addition influence development of pain, tissue damage, ileus, tachycardia and other hemodynamic disturbances. Preoperative fasting has shown an increase of surgical stress and to impact catabolic processes which secondarily may lead to insulin resistance and hyperglycemia in non-diabetic patients. Insulin resistance and hyperglycaemia are known to increase the incidence of postoperative infections. Previous studies have also shown that prolonged fasting increases the incidence of gastrointestinal problems. A 12 hour fast before surgery has shown delayed recovery. Studies have shown that patients undergoing lung cancer surgery suffer from multiple symptoms and experience discomfort in the postoperative phase. Symptoms include dyspnea, fatigue, pain, weakness, cough, dry mouth, nervousness, difficulty sleeping, stomach-/intestinal-problems and lack of appetite. Carbohydrate-rich supplements have shown a positive effect on other perioperative symptoms and measures, but is to our knowledge currently not investigated in lung cancer surgery. Therefore, there is a need to explore the possible advantages of preoperative oral carbohydrate loading in lung cancer surgery. The primary aim of this study is to investigate whether preoperative carbohydrate loading with PreOp® provides less postoperative discomfort in the early postoperative phase measured by Quality of Recovery-40 (QoR-40), a validated and widely used measure of quality of recovery. The secondary aim is to investigate if preoperative loading with carbohydrates affect the incidence of postoperative complications such as stomach-/intestinal problems and heart rhythm disorder, in addition to contribute to faster mobilization and to reduce hospital length of stay. This study may provide important data regarding the lung cancer patients perioperative symptoms, complications and well-being when using a carbohydrate-rich supplement as intervention to standard of care. In this study, the intervention group will be given 800ml of a oral carbohydrate supplement, PreOp®, the night before surgery and 400ml of the same supplement, PreOp®, 2-4 hours prior to surgery. The control group will be fasted from 24h, the night before surgery, in accordance to the departements standard of care. Both groups, the interventional and the control group, will follow the department's perioperative course with regard to anesthetic and surgical procedures.

Interventions

DIETARY_SUPPLEMENTPreOp®

No preoperative drink.

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

adult patients undergoing elective video-assisted thoracoscopic surgery due to lung neoplasms. * ability to understand and speak Norwegian

Exclusion criteria

* impaired gastric emptying * diabetes * ongoing treatment for pain * ongoing infection

Design outcomes

Primary

MeasureTime frameDescription
Postoperative discomfort measured by the questionnaire Quality of recovery 40 (QoR-40) measured on the first postoperative day.First postoperative dayPostoperative discomfort measured by the questionnaire Quality of recovery 40 (QoR-40) measured on the first postoperative day.

Secondary

MeasureTime frameDescription
Gastrointestinal discomfort postoperatively.First seven postoperative days.Number of patients experiencing nausea, vomiting, diarrhea and/or obstipation.
Heart rhythm disturbances postoperatively.First seven postoperative days.Number of patients with arrhythmia lasting more than 5 min or treated with antiarrhythmic agents.
Time to mobilization.First seven postoperative days.Time to mobilization out of bed (to chair or walking) as registered by the attending nurse.
Length of stayFirst seven postoperative days.Length of hospital stay to discharge for index admission.

Countries

Norway

Contacts

Primary ContactPer Reidar Woldbæk, MD, PhD
UXPEWO@ous-hf.no+4798895427
Backup ContactAstrid B. Krohn-Hansen, bachelor
astkro@ous-hf.no+4723015453

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026